Global Gene Synthesis Market
Pharmaceuticals

How Will The Gene Synthesis Market Globally Expand In 2023?

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s gene synthesis market report forecasts the gene synthesis market size to grow to $5.81 Billion by 2027, with a CAGR (compound annual growth rate) of more than 20%.

Learn More On The Gene Synthesis Market Report 2023 – https://www.thebusinessresearchcompany.com/report/gene-synthesis-market-global-market-report

Gene Synthesis Market Size Forecast
The global gene synthesis market is expected to grow from $2.32 billion in 2022 to $2.80 billion in 2023 at a compound annual growth rate (CAGR) of 20.43%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The global gene synthesis market size is expected to reach $5.81 billion in 2027 at a CAGR of 20.05%.

North America held the largest gene synthesis market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Gene Synthesis Market Driver ­– Increased Prevalence Of Chronic Infectious Diseases
According to the World Health Organisation, a United Nations body based in Geneva that is responsible for international public health, 1.6 million people will die from tuberculosis (TB) in 2021. TB is the 13th largest cause of mortality worldwide and the second leading infectious killer after COVID-19 (behind HIV/AIDS). As a result, the rise in the prevalence of chronic infectious diseases is propelling the gene synthesis industry forward.

Request for A Sample Of The Global Gene Synthesis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10084&type=smp

Key Gene Synthesis Market Trend – Technological Advancement
Companies in the gene synthesis market are embracing new technologies in order to maintain their market position. DNA Script SAS, a DNA printing pioneer based in France, for example, debuted its SYNTAX platform in June 2021, which is a benchtop nucleic acid printer powered by Enzymatic DNA Synthesis (EDS) technology. The SYNTAX System is a fully integrated, automated printer that simultaneously synthesises 96 DNA oligos, each of which can be up to 60 nucleotides long, and delivers them ready for use in molecular biology and genomics procedures. The SYNTAX System produces 20mers in about 6 hours, offering same-day results, and may produce up to 60mers in about 13 hours, allowing it to run efficiently.

Gene Synthesis Market Segment
1) By Method: Solid-Phase Synthesis, Chip-Based Synthesis, Pcr-Based Enzyme Synthesis
2) By Service: Antibody DNA Synthesis, Viral DNA Synthesis, Other Services
3) By Application: Gene And Cell Therapy Development, Vaccine Development, Disease Diagnosis, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Contract Research Organizations

Gene Synthesis Market Major Players and Strategies
Major players in the gene synthesis market are Genscript Biotech Corporation, Brooks Automation Inc. (GENEWIZ), Boster Biological Technology Ltd., Twist Bioscience Corp., ProteoGenix Inc., Biomatik Corporation, ProMab Biotechnologies Inc., Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., OriGene Technologies Inc., GenScript Corp., Eurofins Scientific SE, Merck KGaA, Codex DNA, Genewiz Inc., and Eurofins Genomics LLC.

Swift Biosciences Inc. was acquired for an unknown sum in March 2021 by Integrated DNA Technologies Inc. (Danaher Corporation), a biotechnology research business based in the United States. With the acquisition of Swift Biosciences Inc., IDT will be able to provide its customers with a greater range of NGS (next-generation sequencing) products and services, including targeted sequencing solutions and other cutting-edge NGS technologies. Swift Biosciences Inc. is a biotechnology business established in the United States that specialises in next-generation sequencing (NGS).

The Gene Synthesis Global Market Report 2023 covers regional data on gene synthesis market size, gene synthesis market trends and drivers, opportunities, strategies, and gene synthesis market competitor analysis. The countries covered in the gene synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Gene synthesis is the process of chemically constructing a strand of DNA (deoxyribonucleic acid) base by base. Gene synthesis can be used to create recombinant DNA molecules, protein engineering, gene therapy, and synthetic biology, among other things.

View More Reports Related To The Gene Synthesis Market –
Gene Editing Global Market Report 2023
Gene Therapy Global Market Report 2023
Genetic Testing Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn:
https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: